Reuters logo
2 months ago
BRIEF-Suven Life Sciences says initiation of phase 1 clinical trial of Suvn-911
May 25, 2017 / 4:48 AM / 2 months ago

BRIEF-Suven Life Sciences says initiation of phase 1 clinical trial of Suvn-911

1 Min Read

May 25 (Reuters) - Suven Life Sciences Ltd

* Says Suven Life Sciences announces initiation of phase 1 clinical trial and first dosing of Suvn-911

* Says drug used for treatment of major depressive disorder Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below